Dr. Eva M. Hernando-Monge shares how her research on melanoma has changed directions and expanded how she鈥檚 learned from other researchers at Perlmutter Cancer Center.
IMAGE: KARSTEN MORAN
In a conversation with the American Cancer Society鈥檚 TheoryLab podcast, , professor in the and assistant dean for research integration, and , associate professor in the Department of Pathology, both members of 嘿嘿视频 Health鈥檚 Perlmutter Cancer Center, speak about their research, challenges they face in understanding cancer, and more.
Dr. Hernando-Monge, who studies melanoma metastasis, says there has been a great deal of progress in treating people with melanoma, but there are still people who do not respond to treatment or experience side effects of the treatment.
鈥淲hen I started working in cancer, I was just looking at the cancer cells. Now I know that this is a very narrow vision, and I need to understand better how the cancer cells talk with their neighbors,鈥 Dr. Hernando-Monge says. 鈥淎s an investigator, my dream is to understand better those interactions and see how we can attack them to make cancer cells much more vulnerable and much more responsive to the therapies that we have and to new therapies.鈥
While the focus of Dr. Papagiannakopoulos鈥檚 research is lung cancer, he says there is overlap with Dr. Hernando-Monge鈥檚 melanoma research and with other investigators at Perlmutter Cancer Center who study other cancers.
鈥淲e do often exchange models, and we do exchange tools, to be able to study these processes in both lung cancer and melanoma,鈥 Dr. Papagiannakopoulos says. 鈥淎nd one of the reasons I think we have a fantastic environment at 嘿嘿视频 is because of the fact that we鈥檙e a very close community, and we communicate very often, and we discuss each other鈥檚 science very often, and there鈥檚 a lot of synergy and overlap and ability to collaborate.鈥
Listen to Dr. Hernando-Monge鈥檚 and Dr. Papagiannakopoulos鈥檚 entire interview on .
